Mechanism of 11C-acetate uptake in renal cell carcinoma and related experimental research

Jun-yan XU,Yu-jia ZHENG,Jian-min LUO,Jian-ping ZHANG,Ying-jian ZHANG,Jing-yi CHENG,Ding-wei YE
2014-01-01
Abstract:Objective The sensitivity of diagnosing renal cell carcinoma (RCC) by 11C-acetate (11C-AC) PET/CT is higher than 18F-fluorodeoxyglucose (18F-FDG). However, the mechanism of 11C-AC uptake in the tumor is not definite. The present paper aims to identify the correlation between 11C-AC uptake and fatty acid synthesis of cell membrane. Methods In vitro cell uptake and inhibition: 786-0, ACNH and Caki-1 (human renal carcinoma) were cultured, and then treated with C75 (a FAS inhibitor) and dimethyl sulfoxide (DMSO, as control). After 11C-AC was added to cells for 30 min, the lysis extracts were measured in a γ-counter and the protein contents were determined. Then, FAS expression was determined by Western blotting. Micro PET/CT: 786-0-bearing nude mice were scanned by 11C-AC PET/CT and tumor to soft tissue ratios were measured. After imaging, the mice were euthanized, and the tumors were excised for immunohistochemical analysis. Results The 786-0 cells treated with C75 showed inhibition uptake by 31.42% (P=0.013) compared with the control cells. There were no significant differences in 11C-AC uptake between treated cells and control cells for ACNH and Caki-1 cell lines. The visual inspection of the Western blotting results revealed significant differences in band intensity for 786-0 cells, but no differences were found in band intensity for the other two cell lines. The tumors showed significant uptake in micro PET/CT and strong positive in immunohistochemical analysis of FAS expression. Conclusion The 11C-AC uptake in the primary sites of renal clear cell carcinoma was related to the expression of FAS, but different pathological types of renal tumors may utilize acetate through other metabolic pathways.
What problem does this paper attempt to address?